Triple

T22651358
Position Surface form Disambiguated ID Type / Status
Subject Regulation (EC) No 1394/2007 E559101 entity
Predicate officialName P66 FINISHED
Object Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products — NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products | Statement: [Regulation (EC) No 1394/2007, officialName, Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products
Context triple: [Regulation (EC) No 1394/2007, officialName, Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products]
  • A. Regulation (EC) No 1394/2007 chosen
    Regulation (EC) No 1394/2007 is the core EU legal framework governing advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies, setting specific rules for their authorization, supervision, and pharmacovigilance.
  • B. Regulation (EC) No 141/2000 on orphan medicinal products
    Regulation (EC) No 141/2000 on orphan medicinal products is a key European Union law that establishes incentives and a special approval framework to encourage the development and marketing of medicines for rare diseases.
  • C. Regulation (EU) No 1094/2010
    Regulation (EU) No 1094/2010 is an EU legislative act that established the European Insurance and Occupational Pensions Authority (EIOPA) and set out its powers and supervisory framework for insurance and pension markets in the European Union.
  • D. Regulation (EC) No 726/2004
    Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
  • E. Regulation (EC) No 715/2007
    Regulation (EC) No 715/2007 is a key European Union law that sets emission standards and requirements for the type approval of light passenger and commercial vehicles, forming the basis for the Euro 5 and Euro 6 emission limits.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e245489dd88190b1f674acf61c8769 completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1703c5538819089d9b5349f26ea6d completed April 29, 2026, 2:43 a.m.
Created at: April 17, 2026, 3:06 p.m.